Nexus Pharmaceuticals Recalls Benztropine Mesylate Injection Due to Glass Particulates
Nexus Pharmaceuticals is recalling 46,185 vials of Benztropine Mesylate Injection due to the presence of glass delamination flakes.
- Product
- Benztropine Mesylate Injection, USP, 2 mg/mL(1 mg/1 mL), 2 mL Single Dose Vial, Rx only, Manufactured in the USA for Nexus Pharmaceuticals Inc, Lincolnshire, IL 60069, NDC 14789-300-02
- Category
- Drug
- Distribution
- Distributed nationwide